Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Host genomics and HCV personalized medicine.

Annals of clinical and laboratory science - 1 Jan 2012

Slev Patricia

Abstract excerpt

It is estimated that there are 4.0 million individuals chronically infected with Hepatitis C virus (HCV) in the US. Due to the slow progression of disease, the incidence of HCV has declined in the last two decades. However, it is anticipated that the number of individuals requiring treatment for liver disease associated with HCV will increase for years to come. Until 2011, HCV genotype 1 infections were treated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Precision Medicine
Share to Treatment Outcome
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome, Human

Share to Genomics

Share to Hepatitis C

Share to Interferons

Share to Interleukins

Source

Identifiers

PMID: 23090731

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Host genomics and HCV personalized medicine.PMID 23090731Read ↗

Host genomics and HCV treatment response.Semantic proximity Read ↗

The recent breakthroughs in the understanding of host genomics in hepatitis C.Semantic proximity Read ↗

Natural history and clinical response: "it's the virus, stupid, or is it the host?".Semantic proximity Read ↗

Pharmacogenetics of hepatitis CSemantic proximity Read ↗

The role of viral and host genetics in natural history and treatment of chronic HCV infection.Semantic proximity Read ↗

IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.Semantic proximity Read ↗

Host genetics of HCV disease — IL28BSemantic proximity Read ↗

Role of viral and host factors in interferon based therapy of hepatitis C virus infection.Semantic proximity Read ↗

Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis C.Semantic proximity Read ↗

IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection.Semantic proximity Read ↗

Genomics and HCV infection: progression of fibrosis and treatment response.Semantic proximity Read ↗

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.